Pfizer to Withdraw Cancer Drug Mylotarg

more+
less-

The Food and Drug Administration said Monday Pfizer Inc. is withdrawing its cancer drug Mylotarg from the U.S. market after a clinical study showed the drug wasn’t effective and had more safety problems.

Please see full article below for more information.


LOADING PDF: If there are any problems, click here to download the file.

×

Expand Your Reach

JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...

Learn More  or  Schedule a demo